Davey F R, Gatter K C, Ralfkiaer E, Pulford K A, Krissansen G W, Mason D Y
SUNY Health Science Center at Syracuse 13210.
Am J Pathol. 1987 Oct;129(1):54-63.
The use of monoclonal and polyclonal antibodies for the immunophenotyping of non-Hodgkin's lymphomas in paraffin-embedded tissue has been limited by the fact that most antigens on lymphoid cells are denatured by histologic fixation, dehydration, and embedment. In this article the authors have analyzed a small panel of antibodies which represent exceptions to this rule, in that they identify denaturation-resistant determinants on leukocyte antigens in paraffin-embedded tissue. Monoclonal antibodies L26 [corrected] and 4KB5 label preferentially B cells, monoclonal antibody UCHL1 stains predominantly T cells, and monoclonal antibody MAC 387 reacts with granulocytes and some macrophages. A polyclonal antiserum raised against purified CD3 (T3) antigen, a T-cell-specific molecule, was also employed. This antibody panel was used to immunophenotype routinely processed tissue biopsy specimens from 61 non-Hodgkin's lymphomas (all of which had been previously phenotyped in cryostat sections). The lineage of the neoplastic cells was correctly identified in 32 of 34 (94%) cases of B-cell lymphoma, in 19 of 19 (100%) cases of T-cell neoplasm, and in 2 of 4 (50%) cases of histiocytic malignancy. It is concluded that this combination of antibodies is helpful in immunophenotyping non-Hodgkin's lymphomas when only paraffin-embedded tissue sections are available, although additional reagents of higher specificity are required to improve the identification of lymphomas.
单克隆抗体和多克隆抗体用于石蜡包埋组织中非霍奇金淋巴瘤的免疫分型,受到以下事实的限制:淋巴样细胞上的大多数抗原会因组织学固定、脱水和包埋而变性。在本文中,作者分析了一小批抗体,它们是这一规律的例外,因为它们能识别石蜡包埋组织中白细胞抗原上抗变性的决定簇。单克隆抗体L26[已校正]和4KB5优先标记B细胞,单克隆抗体UCHL1主要染色T细胞,单克隆抗体MAC 387与粒细胞和一些巨噬细胞反应。还使用了一种针对纯化的CD3(T3)抗原(一种T细胞特异性分子)产生的多克隆抗血清。该抗体组合用于对61例非霍奇金淋巴瘤的常规处理组织活检标本进行免疫分型(所有标本之前已在冰冻切片中进行过表型分析)。在34例B细胞淋巴瘤中的32例(94%)、19例T细胞肿瘤中的19例(100%)以及4例组织细胞恶性肿瘤中的2例(50%)中,肿瘤细胞的谱系被正确识别。得出的结论是,当只有石蜡包埋的组织切片可用时,这种抗体组合有助于对非霍奇金淋巴瘤进行免疫分型,尽管需要额外的更高特异性的试剂来改进淋巴瘤的识别。